#biotech
Every summary, chronological. Filter by category, tag, or source from the rail.
Tag · #biotech
Closing the Data Gap in AI-Driven Drug Discovery
Current AI drug discovery models fail because they rely on static, non-human data. Vivodyne is addressing this by using autonomous robotic labs to generate causal, human-tissue-based data to train more effective models.
TechCrunch — AI
GPT-Rosalind: Scaling AI for Life Sciences Research
OpenAI has updated GPT-Rosalind, a specialized model for life sciences that integrates agentic coding, tool-use, and domain-specific reasoning to automate complex research workflows from drug discovery to genomics.
OpenAI News
Showing 2 of 2